Impact of Age Examined for Ticagrelor Monotherapy After PCI

WEDNESDAY, July 7, 2021 -- For patients undergoing percutaneous coronary intervention, ticagrelor monotherapy following three months of dual antiplatelet therapy significantly reduces clinically relevant bleeding compared with ticagrelor with...

https://www.drugs.com/news/impact-age-examined-ticagrelor-monotherapy-after-pci-...

Source: Drugs.com - Pharma News - July 7, 2021 Category: Pharmaceuticals Source Type: news

More News: Angioplasty | Bleeding | Coronary Angioplasty | Percutaneous Coronary Intervention | Pharmaceuticals